Screening for CDG type Ia in Joubert syndrome

Éva Morava, Beatrix Cser, Judit Kárteszl, Karin Huljben, Laszlo Szönyi, Gyorgy Kosztolányi, Ron Wevers

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Background: The features of Joubert syndrome include hypotonia, ataxia, characteristic neuro-imaging findings, episodic hypoventilation, psychomotor retardation, and abnormal eye movements. Common symptoms in congenital disorders of glycosylation (CDG) type Ia are muscle hypotonia, cerebellar hypoplasia, ataxia, mental retardation, ophthalmologic involvement, failure to thrive, abnormal fat distribution, and hepatopathy. It has been postulated that some Joubert syndrome patients might have an underlying disorder of protein glycosylation. Material/Methods: Screening for disorders of glycosylation was performed in five children diagnosed with Joubert syndrome. Data were retrospectively collected from clinical charts, the patients were reexamined by clinical geneticists, and available neuro-imaging data were also reanalyzed. Diagnoses were established based on results of serum transferrin isoelectric focusing, phosphomannomutase enzyme activity measurements, and DNA mutation analysis. Results: We confirmed the diagnoses of CDG type Ia in two of the five children originally diagnosed with Joubert syndrome. The symptoms of the two syndromes were clearly distinguishable. Conclusions: Syndromic patients with congenital vermis malformations should be screened for congenital disorders of glycosylation.

Original languageEnglish (US)
Pages (from-to)CR469-CR472
JournalMedical Science Monitor
Issue number8
StatePublished - Aug 1 2004


  • CDG
  • Glycosylation
  • Joubert syndrome
  • Vermis hypoplasia

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Screening for CDG type Ia in Joubert syndrome'. Together they form a unique fingerprint.

Cite this